Vanecková I, Skaroupková P, Dvorák P, Certíková Chábová V, Tesar V, Bader M, Ganten D, Kramer H J
Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Vídenská 1958/9, CZ-140 21 Prague 4, Czech Republic.
Physiol Res. 2005;54(1):17-24. doi: 10.33549/physiolres.930596.
The present study was performed to evaluate the effects of sodium intake and of chronic cyclooxygenase-2 (COX-2) inhibition on systolic blood pressure (SBP) in heterozygous male transgenic rats harboring the mouse Ren-2 renin gene (TGR) and in transgene-negative normotensive Hannover Sprague-Dawley (HanSD). Twenty-eight days old TGR and HanSD were randomly assigned to groups fed either normal salt (NS) or low sodium (LS) diets. COX-2 blockade was achieved with NS-398 (1 mg x kg(-1).day(-1) in drinking water). During an experimental period of 26 days, SBP was repeatedly measured by tail plethysmography in conscious animals. We found that the LS diet prevented the development of hypertension in TGR and did not change SBP in HanSD. Low sodium intake also prevented proteinuria and cardiac hypertrophy in TGR. On the other hand, irrespective of sodium intake chronic COX-2 inhibition did not alter the course of SBP in either TGR or HanSD. The present data indicate that TGR exhibit an important salt-sensitive component in the developmental phase of hypertension. They also suggest that systemic COX-2-derived prostaglandins do not act as vasodilatory counterregulatory agents in TGR in which an exaggerated vascular responsiveness to angiotensin II is assumed as the pathophysiological mechanism in the development of hypertension.
本研究旨在评估钠摄入和慢性环氧化酶-2(COX-2)抑制对携带小鼠Ren-2肾素基因的杂合雄性转基因大鼠(TGR)和转基因阴性的正常血压汉诺威-斯普拉格-道利大鼠(HanSD)收缩压(SBP)的影响。28日龄的TGR和HanSD被随机分为正常盐(NS)饮食组或低钠(LS)饮食组。通过在饮用水中添加NS-398(1 mg·kg⁻¹·天⁻¹)来实现COX-2阻断。在26天的实验期内,通过尾容积描记法对清醒动物反复测量SBP。我们发现,LS饮食可预防TGR高血压的发生,且对HanSD的SBP无影响。低钠摄入还可预防TGR的蛋白尿和心脏肥大。另一方面,无论钠摄入情况如何,慢性COX-2抑制均不会改变TGR或HanSD的SBP进程。目前的数据表明,TGR在高血压发展阶段表现出重要的盐敏感性成分。它们还表明,全身性COX-2衍生的前列腺素在TGR中不作为血管舒张性反调节因子起作用,在TGR中,对血管紧张素II的过度血管反应性被认为是高血压发展的病理生理机制。